Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 5, 2020
Evaluation of in vitro absorption, distribution, metabolism, and excretion and assessment of drug-drug interaction of rucaparib, an orally potent poly(ADP-ribose) polymerase inhibitorMingxiang Liao, Sarah Jaw-Tsai, Jeri Beltman, et al.
Clinical Pharmacokinetics|September 15, 2022
Clinical Pharmacokinetics and Pharmacodynamics of RucaparibMingxiang Liao, Jeri Beltman, Heidi Giordano, et al.
Protein Expression and Purification|July 4, 2006
Expression and characterization of recombinant gamma-tryptaseJing Yuan, Jeri Beltman, Erik Gjerstad, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2022
Population pharmacokinetics of rucaparib in patients with advanced ovarian cancer or other solid tumorsMichelle L Green, Shu Chin Ma, Sandra Goble, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2006
Design and synthesis of selective keto-1,2,4-oxadiazole-based tryptase inhibitorsJames T Palmer, Robert M Rydzewski, Rohan V Mendonca, et al.
Clinical and Translational Science|November 15, 2018
Evaluation of Drug-Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P-gp Substrates in Patients With an Advanced Solid TumorJim J Xiao, Dorota Nowak, Rodryg Ramlau, et al.
Cancer Chemotherapy and Pharmacology|April 28, 2021
Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairmentNikolay Grechko, Viera Skarbova, Monika Tomaszewska-Kiecana, et al.
Investigational New Drugs|June 29, 2019
Evaluation of absorption, distribution, metabolism, and excretion of [14C]-rucaparib, a poly(ADP-ribose) polymerase inhibitor, in patients with advanced solid tumorsMingxiang Liao, Simon Watkins, Eileen Nash, et al.
Gynecologic Oncology|March 23, 2021
Population exposure-efficacy and exposure-safety analyses for rucaparib in patients with recurrent ovarian carcinoma from Study 10 and ARIEL2Gottfried E Konecny, Amit M Oza, Anna V Tinker, et al.
Pageof 1